25Jan 2024
Breakthrough 3D Imaging Tool Advances Precision Immunotherapy for Triple-Negative Breast Cancer

Breakthrough 3D Imaging Tool Advances Precision Immunotherapy for Triple-Negative Breast Cancer

Achieving precise patient selection for immunotherapy remains challenging, and a suitable digital pathology solution for spatial analysis of PD-1/PD-L1 inhibitors needs to be improved. Introducing a novel computer-assisted tool for three-dimensional (3D) imaging of PD-L1 expression in BC specimens, the method demonstrated feasibility and strong agreement with traditional two-dimensional (2D) staining techniques. Results showcased heterogeneous PD-L1 expression across BC tissue layers, with 30% breaching the 1% threshold for PD-1/PD-L1 inhibitor eligibility.

  • #neurology

Like

Save

Share